Lantern PharmaLTRN
13F holders, Q1 2024 (March 31)34holders
1famous investor
$8.80avg. 13F price*
At the end of Q1 2024, 34 institutions reported holding Lantern Pharma Inc. (LTRN) in their 13F filings. The largest holders were Vanguard Group Inc. ($3.2M), NewEdge Advisors, LLC ($1.4M) and Geode Capital Management, LLC ($769K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lantern Pharma Inc.
- CUSIP
- 51654W101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $958K |
| Exits | 6 | $699K |
Ownership 34 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.4% | 363,720 | $3.2M |
| NewEdge Advisors, LLC | 0.01% | Reduce -3.3% | 160,532 | $1.4M |
| Geode Capital Management, LLC | 0.00% | Reduce -8.1% | 87,374 | $769K |
| Renaissance Technologies | 0.00% | Add +50.0% | 65,700 | $578K |
| CM Management, LLC | 0.48% | Reduce -18.8% | 65,000 | $572K |
| Redmond Asset Management, LLC | 0.11% | Reduce -0.5% | 40,462 | $356K |
| Horizon Kinetics Asset Management LLC | 0.00% | No change | 28,791 | $253K |
| Sigma Planning Corp | 0.01% | Add +126.1% | 26,850 | $236K |
| Bank of New York Mellon Corp | 0.00% | Add +0.0% | 26,482 | $233K |
| Susquehanna International Group, LLP | 0.00% | New | 25,784 | $227K |
| UBS Group AG | 0.00% | Reduce -1.8% | 25,500 | $224K |
| State Street Corp. | 0.00% | Reduce -9.7% | 25,052 | $220K |
| Pathway Financial Advisors LLC | 0.06% | Reduce -12.3% | 25,001 | $220K |
| Jane Street Group, LLC | 0.00% | New | 24,872 | $219K |
| BlackRock Inc. | 0.00% | Reduce -1.5% | 19,659 | $173K |
| Tocqueville Asset Management L.P. | 0.00% | New | 19,000 | $167K |
| Northern Trust Corp. | 0.00% | Add +1.8% | 12,823 | $113K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | New | 12,004 | $106K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,828 | $104K |
| Avantax Planning Partners, Inc. | 0.00% | New | 11,640 | $102K |
| Tucker Asset Management LLC | 0.02% | New | 11,500 | $101K |
| Wells Fargo & Company | 0.00% | Add +69.4% | 7,616 | $67K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +188.3% | 3,356 | $30K |
| Simplex Trading, LLC | 0.00% | New | 2,928 | $25K |
| Qube Research & Technologies Ltd | 0.00% | Add +85000.0% | 1,702 | $15K |
| Indiana Trust & Investment Management Co | 0.00% | New | 750 | $7K |
| Morgan Stanley | 0.00% | Add +19.2% | 715 | $6K |
| Wolff Wiese Magana LLC | 0.00% | No change | 600 | $5K |
| Osaic Holdings, Inc. | 0.00% | Add +105.0% | 410 | $4K |
| PNC Financial Services Group, Inc. | 0.00% | New | 250 | $2K |
| Rhumbline Advisers | 0.00% | No change | 228 | $2K |
| Stone House Investment Management, LLC | 0.00% | New | 200 | $2K |
| Allworth Financial LP | 0.00% | No change | 100 | $880 |
| Royal Bank of Canada | 0.00% | Reduce -90.7% | 8 | $0 |
"% of holder's portfolio" is LTRN's weight in each manager's 13F, not the share of Lantern Pharma Inc. the manager owns.